The financing of drug trials by pharmaceutical companies and its consequences. Part 1: a qualitative, systematic review of the literature on possible influences on the findings, protocols, and quality of drug trials (Q37751910)
Jump to navigation
Jump to search
scientific article published on 23 April 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The financing of drug trials by pharmaceutical companies and its consequences. Part 1: a qualitative, systematic review of the literature on possible influences on the findings, protocols, and quality of drug trials |
scientific article published on 23 April 2010 |
Statements
1 reference
The financing of drug trials by pharmaceutical companies and its consequences. Part 1: a qualitative, systematic review of the literature on possible influences on the findings, protocols, and quality of drug trials (English)
1 reference
Ursula Gundert-Remy
1 reference
Gisela Schott
1 reference
Henry Pachl
1 reference
Ulrich Limbach
1 reference
Wolf-Dieter Ludwig
1 reference
Klaus Lieb
1 reference
23 April 2010
1 reference
1 reference
279-285
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference